Wealthfront Advisers LLC bought a new position in Cardinal Health, Inc. (NYSE:CAH – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 58,873 shares of the company’s stock, valued at approximately $13,986,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in the company. University of Texas Texas AM Investment Management Co. purchased a new stake in Cardinal Health in the fourth quarter worth $26,000. Bank of Jackson Hole Trust purchased a new position in Cardinal Health during the fourth quarter valued at $27,000. Jones Financial Companies Lllp lifted its position in Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares during the period. Palladiem LLC bought a new stake in shares of Cardinal Health during the 4th quarter valued at $28,000. Finally, Indiana Trust & Investment Management Co bought a new position in shares of Cardinal Health in the 1st quarter worth about $29,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on the stock. Mizuho lifted their price target on shares of Cardinal Health from $240.00 to $250.00 and gave the company an “outperform” rating in a research report on Wednesday, August 12th. JPMorgan Chase & Co. raised their target price on shares of Cardinal Health from $215.00 to $260.00 and gave the company a “neutral” rating in a research note on Thursday, August 13th. Bank of America raised their target price on shares of Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. Royal Bank Of Canada started coverage on shares of Cardinal Health in a report on Wednesday. They set an “outperform” rating and a $276.00 target price for the company. Finally, Morgan Stanley boosted their price target on Cardinal Health from $255.00 to $265.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Sixteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $266.56.
Cardinal Health Price Performance
Shares of NYSE:CAH opened at $234.85 on Wednesday. The business has a fifty day moving average price of $231.38 and a 200-day moving average price of $217.51. The company has a market capitalization of $54.62 billion, a PE ratio of 32.48, a PEG ratio of 1.26 and a beta of 0.49. Cardinal Health, Inc. has a 1-year low of $145.87 and a 1-year high of $258.30.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The company had revenue of $63.67 billion for the quarter, compared to analysts’ expectations of $65.15 billion. During the same quarter in the previous year, the business posted $2.08 EPS. Cardinal Health’s revenue was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 12.54 earnings per share for the current fiscal year.
Cardinal Health Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be paid a $0.5158 dividend. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Thursday, October 1st. Cardinal Health’s dividend payout ratio is currently 28.49%.
About Cardinal Health
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Further Reading
- Five stocks we like better than Cardinal Health
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
